Europlasma Shares Outstanding vs. Gross Profit

ALEUP Stock  EUR 0.07  0.01  8.50%   
Based on the key profitability measurements obtained from Europlasma's financial statements, Europlasma SA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Europlasma's ability to earn profits and add value for shareholders.
For Europlasma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Europlasma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Europlasma SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Europlasma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Europlasma SA over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Europlasma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Europlasma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Europlasma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Europlasma SA Gross Profit vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Europlasma's current stock value. Our valuation model uses many indicators to compare Europlasma value to that of its competitors to determine the firm's financial worth.
Europlasma SA is number one stock in shares outstanding category among its peers. It also is number one stock in gross profit category among its peers fabricating about  1.01  of Gross Profit per Shares Outstanding. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Europlasma's earnings, one of the primary drivers of an investment's value.

Europlasma Gross Profit vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Europlasma

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
5.59 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Europlasma

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
5.65 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Europlasma Gross Profit Comparison

Europlasma is currently under evaluation in gross profit category among its peers.

Europlasma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Europlasma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Europlasma will eventually generate negative long term returns. The profitability progress is the general direction of Europlasma's change in net profit over the period of time. It can combine multiple indicators of Europlasma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Europlasma S.A., together with its subsidiaries, engages in plasma solutions, renewable energies, and asbestos waste treatment activities in France. Europlasma S.A. was founded in 1992 and is based in Pessac, France. EUROPLASMA operates under Waste Management classification in France and is traded on Paris Stock Exchange. It employs 116 people.

Europlasma Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Europlasma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Europlasma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Europlasma's important profitability drivers and their relationship over time.

Use Europlasma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Europlasma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Europlasma will appreciate offsetting losses from the drop in the long position's value.

Europlasma Pair Trading

Europlasma SA Pair Trading Analysis

The ability to find closely correlated positions to Europlasma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Europlasma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Europlasma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Europlasma SA to buy it.
The correlation of Europlasma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Europlasma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Europlasma SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Europlasma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Europlasma position

In addition to having Europlasma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Services Thematic Idea Now

Services
Services Theme
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Europlasma Stock Analysis

When running Europlasma's price analysis, check to measure Europlasma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europlasma is operating at the current time. Most of Europlasma's value examination focuses on studying past and present price action to predict the probability of Europlasma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europlasma's price. Additionally, you may evaluate how the addition of Europlasma to your portfolios can decrease your overall portfolio volatility.